Abstract: A water filtration system is provided comprising first and second banks of water filter assemblies, wherein the system is arranged to provide filtered water from one bank of water filter assemblies while using some of the filtered water to reverse flush the other bank of water filtration assemblies. A method of filtering water by passing it through the system is also provided.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: The compounds encompassed by Formula I include compounds which are HIV protease inhibitors and other compounds which can be metabolized in vivo to HIV protease inhibitors. The compounds and their pharmaceutically acceptable salts are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: The compounds encompassed by Formula I include compounds which are HIV protease inhibitors and other compounds which can be metabolized in vivo to HIV protease inhibitors. The compounds and their pharmaceutically acceptable salts are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: In a preferred embodiment, the invention is a mobile communication device having a digital signal processor (DSP), a speaker output node, a local audio source, and an analog front-end (AFE), wherein: (1) the DSP receives a first audio signal corresponding to sound captured by a microphone near a user of the device, (2) if the device is operating in a call mode, the DSP derives a background noise signal from the first audio signal, for subtraction from the first audio signal before transmission to the AFE, and (3) if the device is operating in a non-call mode, then the DSP (i) generates a speaker output signal which substantially corresponds to the first audio signal subtracted from a local audio signal provided by the local audio source and (ii) provides the speaker output signal to a speaker via the speaker output node.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: In a preferred embodiment, the invention is a mobile communication device having a digital signal processor (DSP), a speaker output node, a local audio source, and an analog front-end (AFE), wherein: (1) the DSP receives a first audio signal corresponding to sound captured by a microphone near a user of the device, (2) if the device is operating in a call mode, the DSP derives a background noise signal from the first audio signal, for subtraction from the first audio signal before transmission to the AFE, and (3) if the device is operating in a non-call mode, then the DSP (i) generates a speaker output signal which substantially corresponds to the first audio signal subtracted from a local audio signal provided by the local audio source and (ii) provides the speaker output signal to a speaker via the speaker output node.

Abstract: A system for, and method of, obscuring ambient noise. In one embodiment, the system includes: (1) a background sound generator, (2) a mixer coupled to the background sound generator and (3) a user interface, coupled to the mixer, that, upon a user command, causes the mixer to mix an output of the background sound generator with a transmitted signal. The background sound may be music, white noise, colored noise, out-of-phase ambient noise, simulated alternative ambient noise or any other suitable background sound. The system may be associated with a wireless handset, a wireline handset, central office equipment or any other suitable location or equipment.

Abstract: There is disclosed a keypad apparatus and a method for determining the status of a keypad apparatus. In one embodiment, the keypad apparatus includes a keypad having a plurality of keys and a keypad matrix associated with the keypad and having a switch. The keypad apparatus also includes a cover moveable between an open and a closed position. The keypad apparatus still further includes a means for engaging that cooperates with and allows the switch to provide a status indicating a position of the cover.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: There is disclosed a keypad apparatus and a method for determining the status of a keypad apparatus. In one embodiment, the keypad apparatus includes a keypad having a plurality of keys and a keypad matrix associated with the keypad and having a switch. The keypad apparatus also includes a cover moveable between an open and a closed position. The keypad apparatus still further includes a means for engaging that cooperates with and allows the switch to provide a status indicating a position of the cover.

Abstract: A colored glass curtain wall for a building and a method for constructing the glass curtain wall are disclosed. The colored glass curtain wall comprises a plurality of individual panels interconnected by a support frame. Each individual panel has an inboard sheet and an outboard sheet, both of which are preferably made of glass. At least part of the interior surface of the outboard glass sheet is preferably roughened by either a sandblasting or etching process. The exterior surface of the inboard sheet has a coating of opaque paint corresponding to the roughened portion. A reflective coating may also be applied to either the inboard or outboard sheet.

Abstract: A method for reconditioning a length of air core cable and for discharging moisture from the cable. Gas under pressure is forced into one end of the cable to cause discharge of moisture from an opposite end of the cable. A quantity of fluid solvent and lubricant is injected into the end of the cable and forced by gas under pressure as a unitary charge along the length of the cable.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.